wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q58850040-764C10B1-B612-4907-A650-979986EA48CB
Q58850040-764C10B1-B612-4907-A650-979986EA48CB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58850040-764C10B1-B612-4907-A650-979986EA48CB
Neoadjuvant Immunotherapy With Durvalumab and Tremelimumab for Bladder Cancer Patients Ineligible for Cisplatin
P1050
Q58850040-764C10B1-B612-4907-A650-979986EA48CB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58850040-764C10B1-B612-4907-A650-979986EA48CB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cd228cc29adaf7625e951334bd17fcafb548b35b
P1050
bladder neoplasm